MuscleLedger

Creatine and Cancer: Two Mouse Studies, One Case-Control Study, and the Trials in People With Cancer

No study of people has shown that creatine supplements cause cancer. The worry rests on two Chinese mouse studies of metastasis (2021, 2026), a 2015 case-control study of testicular cancer that measured muscle-building supplements rather than creatine, and cooking chemistry. Five randomised trials in people with cancer found creatine neither helped nor harmed on their main outcomes.

Leon H · Edited by Caroline S · Published 2026-11-16

Illustration: An unbranded creatine tub, empty scoop, and resistance band on a wooden floor in morning light.
Illustration

"Creatine and cancer" is searched about 900 times a month in the US, and the question usually arrives in one of two forms: does creatine cause cancer, from people already taking it, and is creatine safe with cancer, from patients and families. The two have different evidence behind them, and the second has more of it than the first.

This page sets out each source of the worry — what was studied, in whom, at what amount — and then the trials that gave creatine to people who have cancer. It does not say whether anyone with cancer, or a history of it, should take creatine. That belongs with their oncologist.

The short version

Claim in circulation What it rests on Studied in people taking creatine?
Creatine causes cancer Cooking chemistry (heterocyclic amines) Tested — no rise in urine (2015)
Creatine makes tumours spread Two mouse studies, 2021 and 2026 No — volunteers' platelets tested in mice only
Creatine is linked to testicular cancer One case-control study, 2015 Partly — supplement use self-reported, creatine not isolated
Creatine protects muscle in cancer Five randomised trials with results Yes — no benefit over placebo found

Counting what exists

A PubMed search on 16 November 2026 for creatine in the title crossed with cancer, tumour, neoplasm, cachexia or chemotherapy in the title, limited to clinical-trial publication types, returned 8 records. Read one by one, five are randomised trials giving creatine supplements to people with or after cancer, and a sixth is the 2019 published protocol of one of them (PMID 31542747); the other two measure creatine kinase or creatinine in urine and give no creatine supplement.

Without the trial filter, the same title search for creatine and cancer, tumour, tumor, neoplasm, carcinogen or oncology returns 205 records. Most are about creatine kinase, the enzyme, or creatine metabolism inside tumour cells — laboratory biology, not supplement studies. That is worth knowing before reading a headline: "creatine" in a cancer paper's title usually means the body's own creatine system, not a scoop of powder.

Where the "causes cancer" idea comes from: cooked meat

Creatine and creatinine in muscle meat react with sugars and amino acids when meat is cooked at high temperature, forming heterocyclic amines (HCAs) such as PhIP and MeIQx, compounds that are mutagenic in laboratory tests. Food chemists use creatine as one of the precursors when they study HCA formation in grilled patties (Gibis & Weiss 2015, PMID 26445401).

The leap from that chemistry to supplements was tested directly. Pereira and colleagues in São Paulo gave healthy volunteers low- and high-dose creatine for one day and for 30 days, then measured four HCAs in urine with a purpose-built mass-spectrometry method (J Physiol 2015, PMID 26148133):

  • 576 assessments from 149 urine samples.
  • Only 9 were quantifiable — 3 after creatine, 6 after placebo.
  • Case by case, the authors traced the detectable HCAs to what the person had eaten, not to the creatine.

A 2025 analysis of 1,763 US adults in the national NHANES survey found no link between dietary creatine intake (mean 0.83 g a day) and blood or urine carcinogen markers once diet was adjusted for (Baltic et al., Nutr Health 2025, PMID 39469994). One of its authors sits on a creatine manufacturer's advisory board and holds creatine patents, which the paper declares. The São Paulo HCA study is the stronger of the two because it gave the supplement and measured the outcome.

The mouse studies: creatine and metastasis

These are the papers behind most recent headlines, and both deserve to be read for what they did.

Zhang et al., Cell Metabolism, 2021. Chinese Academy of Sciences researchers reported that in mouse models, creatine — from the diet or made by the tumour's own enzyme, GATM — increased colorectal and breast cancer metastasis and shortened survival, through a signalling route the authors traced to Smad2/3, Snail and Slug (PMID 33811821). The abstract closes by calling for "caution when considering dietary creatine to improve muscle mass or treat diseases". The amount used, set against human intake, is discussed on the page that weighs the cancer, diabetes and blood-pressure claims together.

Xie et al., Nature Communications, July 2026. A Fudan University-led group reported a second route: creatine raised levels of the enzyme creatine kinase B in megakaryocytes, the bone-marrow cells that make platelets, producing hyperactive platelets that helped circulating tumour cells seed new tumours in several mouse models (PMID 42449108, full text read 2026-11-16). Knocking out the creatine transporter in those cells, or blocking the STAT5 signal downstream, prevented the effect.

This study also took the question to people, and how it did so matters:

  • 11 healthy volunteers, men and women, took 20 g of creatine a day for 14 days — the size of a common loading phase, held for twice as long.
  • Blood creatine rose above 150 µM by day 3 and stayed there; their platelets aggregated and adhered more readily.
  • Platelets taken after 7 days were injected, with mouse tumour cells, into immunodeficient mice, where they increased metastasis.

What that design cannot show: there was no placebo group (each volunteer was compared with themselves before creatine), the volunteers did not have cancer, and the metastasis was measured in mice. It is evidence that creatine changes human platelets in the laboratory, not evidence that creatine spreads cancer in a person.

The other direction, also in mice. A UCLA group reported that creatine supplementation suppressed tumour growth in several mouse tumour models by powering CD8 T cells, and worked with a PD-1 checkpoint drug (Di Biase et al., J Exp Med 2019, PMID 31628186); a 2023 study found creatine slowed melanoma growth in mice through macrophages (Peng & Saito, PMID 37662917). The mouse literature therefore points both ways — creatine feeding tumour spread in some models and immune attack in others — which is the clearest reason not to carry any of it straight to people.

The testicular cancer study

In 2015 Yale researchers compared 356 men with testicular germ cell cancer with 513 controls in Connecticut and Massachusetts (Li et al., Br J Cancer 2015, PMID 25826226, full text read 2026-11-16). Men were interviewed about 30 kinds of muscle-building supplement powder or pill, used at least weekly for four weeks or more.

Exposure Odds ratio (95% CI)
Ever used any muscle-building supplement 1.65 (1.11–2.46)
First use before age 25 2.21 (1.34–3.63)
Two or more types used 2.77 (1.30–5.91)
More than 36 months of use 2.56 (1.39–4.74)
Products containing both creatine and protein 2.55 (1.05–6.15)

Three limits the paper's own design sets. Use was self-reported years after the fact; the authors argue recall bias is unlikely because the link was not suspected at the time. Creatine was not isolated: the strongest creatine figure is for products that also contained protein, and the supplements in the study included androstenedione and its boosters. And it is one study, not replicated in the decade since; a 2022 commentary by two of its authors restated the hypothesis rather than reporting new data (Girardi et al., Front Nutr 2022, PMID 35155536). The HCA test above was designed partly to check the mechanism this study proposed, and did not find it.

Trials in people who have cancer

The five randomised trials with published results ask a different question from the mouse work: whether creatine helps patients hold on to weight, muscle and strength during or after treatment.

Trial Who Creatine Result against placebo
Jatoi et al. 2017 (Alliance N02C4) 263 evaluable patients, incurable cancer with weight loss 20 g/day × 5 days, then 2 g/day No difference in weight, appetite, quality of life, grip or body composition; survival 230 v 239 days
Norman et al. 2006 31 people with colorectal cancer on chemotherapy, 8 weeks creatine v placebo Muscle function, body cell mass and quality of life unchanged; phase angle up slightly
Fairman et al. 2025 30 men with prostate cancer on hormone therapy, 12 weeks, with exercise creatine v placebo No added gain in lean mass, strength or function
Fairman et al. 2026 27 people treated for colorectal cancer, 10 weeks, with exercise 5 g/day v maltodextrin Feasible; no between-group difference
Parsowith et al. 2024 19 breast cancer survivors, 7 days 20 g/day (4 × 5 g) No effect on power, torque or strength

A sixth, in head and neck cancer (DAHANCA 25A, NCT01025518, 30 people, resistance training with protein and creatine), is listed as completed on the registry; its publications were not read for this page.

Across the five, adverse events were reported as similar to placebo, and no serious adverse event was attributed to creatine. None of the trials measured tumour progression or recurrence as an outcome, so none answers the metastasis question either way. A 2025 systematic review of seven studies and 463 participants concluded that evidence of a meaningful effect on body composition "remains limited" and that creatine "appears safe" in the populations studied (Del Arco et al., Nutr Cancer 2025, PMID 40536429).

Two of the trials disclose industry ties: in the 2026 colorectal pilot, one author advises and consults for creatine manufacturers and AlzChem supplied the creatine and placebo; the 2025 prostate trial declares none.

What is registered and not yet reported

ClinicalTrials.gov, searched 16 November 2026 for creatine as an intervention in cancer, returned 29 records; 12 give creatine to people with or after cancer (the rest use "creatinine" or creatine kinase as a measure).

Status Count Examples
Completed 5 the cancer weight-loss trial (NCT00081250), head and neck (NCT01025518), metastatic prostate (NCT03987217), colorectal (NCT06420726)
Recruiting 3 metastatic prostate, 200 planned (NCT06112990); breast; prostate sarcopenia
Not yet recruiting 2 head and neck (NCT07838090); cognition in early breast cancer, 227 planned (NCT07372144)
Unknown 2 breast (NCT05878106); creatine with curcumin in gastric cancer (NCT05856500)

None of the 12 has posted results on the registry. The metastatic prostate trial (CREATINE-52, protocol published 2024, PMID 38637770) is the one to watch: its title names "attenuate cancer progression", so it is the first registered human trial that will report something close to the question the mouse studies raised.

FDA adverse event reports

The FDA's food and supplement adverse event database (CAERS, through openFDA), queried on 16 November 2026, holds 210 reports naming a product with "creatine" in its brand name. Two list a cancer term: a 2012 report for a 72-year-old man listing prostate, bladder and urethral cancer alongside two other powders and a nutrition drink, and a 2012 report for a 37-year-old man listing a carcinoid tumour alongside a protein bar and drink. A report is a complaint filed to a database, not a finding of cause; two among 210, each with several products, is the extent of it.

What nobody has studied

  • Whether creatine supplements change cancer risk in people — no cohort study has followed supplement users for cancer outcomes.
  • Whether creatine affects metastasis or recurrence in patients; no trial has reported it.
  • Interactions with specific chemotherapy, hormone or immunotherapy drugs.
  • Whether the 2026 platelet changes occur at 3–5 g a day, the amount most commonly reported on labels, rather than 20 g.
  • Any human replication of the testicular cancer association.

For anyone with cancer or a history of it

The questions here are ones for the oncology team: the mouse findings concern spread of existing tumours, and the trials in patients were not built to rule that out. Useful to bring: the product, its label amount, any other ingredients on the label, and the date of starting. Kidney function tests are also affected — creatine raises creatinine without changing filtration, explained on what creatine does to a blood test — which matters where drug doses are set from kidney results. The wider safety record in healthy users is on is creatine bad for you.

Sources and dates

  • Jatoi A et al. A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. Ann Oncol 2017;28(8):1957–63. PMID 28475678, abstract read 2026-11-16.
  • Norman K et al. Effects of creatine supplementation on nutritional status, muscle function and quality of life in patients with colorectal cancer. Clin Nutr 2006;25(4):596–605. PMID 16701923.
  • Fairman CM et al. Creatine supplementation does not add to resistance training effects in prostate cancer patients under androgen deprivation therapy. J Sci Med Sport 2025;28(2):118–24. PMID 39366880.
  • Fairman CM et al. Examining the feasibility and preliminary effects of resistance exercise training and creatine supplementation in individuals treated for colorectal cancer. PLoS One 2026;21(7):e0353630. PMID 42455839.
  • Parsowith EJ et al. Impact of short-term creatine supplementation on muscular performance among breast cancer survivors. Nutrients 2024;16(7):979. PMID 38613014.
  • Del Arco A et al. Effect of creatine supplementation on body composition in cancer patients: a systematic review. Nutr Cancer 2025;77(7–8):760–71. PMID 40536429.
  • Zhang L et al. Creatine promotes cancer metastasis through activation of Smad2/3. Cell Metab 2021;33(6):1111–23. PMID 33811821.
  • Xie S et al. Exogenous creatine supplementation promotes tumor metastasis via megakaryocyte creatine kinase B-STAT5B signaling. Nat Commun 2026;17:8662. PMID 42449108, full text (PMC13490413) read 2026-11-16.
  • Di Biase S et al. Creatine uptake regulates CD8 T cell antitumor immunity. J Exp Med 2019;216(12):2869–82. PMID 31628186.
  • Peng Z, Saito S. Creatine supplementation enhances anti-tumor immunity by promoting adenosine triphosphate production in macrophages. Front Immunol 2023;14:1176956. PMID 37662917.
  • Li N et al. Muscle-building supplement use and increased risk of testicular germ cell cancer in men from Connecticut and Massachusetts. Br J Cancer 2015;112(7):1247–50. PMID 25826226, full text (PMC4385953) read 2026-11-16.
  • Girardi KG, Zheng T, Zhu Y. Can muscle building supplements increase testicular cancer risk? Front Nutr 2022;9:778426. PMID 35155536.
  • Pereira RT et al. Can creatine supplementation form carcinogenic heterocyclic amines in humans? J Physiol 2015;593(17):3959–71. PMID 26148133, abstract read 2026-11-16.
  • Baltic S, Grasaas E, Ostojic SM. Dietary creatine and carcinogenic biomarkers in adult population. Nutr Health 2025;31(1):53–8. PMID 39469994.
  • Gibis M, Weiss J. Impact of precursors creatine, creatinine, and glucose on the formation of heterocyclic aromatic amines in grilled patties of various animal species. J Food Sci 2015. PMID 26445401.
  • PubMed searches run 2026-11-16: creatine[ti] × cancer/tumour/neoplasm/cachexia/chemotherapy[ti], trial publication types — 8 records; creatine[ti] × cancer terms[ti], any type — 205 records.
  • ClinicalTrials.gov API v2, intervention "creatine" × condition "cancer", run 2026-11-16: 29 records, 12 giving creatine to people with or after cancer, 0 with posted results.
  • FDA CAERS via openFDA (api.fda.gov/food/event.json), brand name containing "creatine", run 2026-11-16: 210 reports, 2 with a cancer reaction term.

Frequently asked questions

Does creatine cause cancer?

No study in people has shown that it does. The claim draws on three kinds of evidence: mouse studies in which creatine helped existing tumours spread, a case-control study that linked muscle-building supplements in general to testicular cancer, and the chemistry of meat cooked at high heat. None of these is a study of creatine supplements causing a cancer in a person, and a test of urine from people taking creatine found no rise in the cooking-related carcinogens.

Does creatine make cancer spread?

In mice, two research groups have reported that it can. A 2021 study found dietary creatine increased colorectal and breast cancer metastasis, and a 2026 study found creatine made platelets help tumour cells spread, including platelets taken from 11 healthy volunteers and tested in mice. No study has measured metastasis in people with cancer who took creatine. Anyone being treated for cancer has this question for their oncologist.

Is creatine safe during chemotherapy?

Small trials have given creatine during or after treatment: 30 people with colorectal cancer on chemotherapy for 8 weeks, 263 people with advanced cancer and weight loss, men with prostate cancer on hormone therapy. They reported adverse effects similar to placebo, but none was designed to test whether creatine changes how chemotherapy works or how a tumour behaves. The decision belongs with the treating oncology team.

Can creatine cause testicular cancer?

One study has looked. Men with testicular germ cell cancer were more likely than controls to report having used muscle-building supplements (odds ratio 1.65), and the figure was 2.55 for products combining creatine and protein. The study measured remembered supplement use, could not separate creatine from the other ingredients, and has not been repeated. It shows an association, not that creatine causes the cancer.

Does creatine help cancer patients keep muscle?

The trials so far say no added effect. In men with prostate cancer on hormone therapy, people with colorectal cancer and breast cancer survivors, creatine with or without exercise did not improve muscle or strength more than placebo. In the largest trial, 263 patients with cancer weight loss, it did not help weight, appetite or grip. A 2025 review of seven studies reached the same view.

Is it safe to eat meat if creatine forms carcinogens?

That question is about cooking, not supplements. Creatine and creatinine in meat react with sugars and amino acids at high temperatures to form heterocyclic amines, which is why grilled and pan-fried meat contains them. A creatine supplement is not heated with meat, and a test of people taking it found no increase in those compounds in urine.